BAUSCH HEALTH IRELAND LIMITED et al v. MYLAN LABORATORIES LTD. et al

  1. March 30, 2023

    Patent Suit Over Generic IBS Drugs Will Go On

    West Virginia's top judge on Thursday rejected arguments from the makers of gastrointestinal drug Trulance to hand the companies a win in their effort to assert patents to block several Mylan generics from competing with the drug.

  2. March 10, 2022

    Bausch, Salix's Trimmed IBS Drug IP Suit Moves to W.Va.

    A New Jersey federal judge on Tuesday dismissed several Mylan entities from a patent suit relating to their purported plans to market generic versions of gastrointestinal drug Trulance, while also tossing a number of patent claims and sending the remainder to West Virginia federal court.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!